BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29484036)

  • 1. Genetic Association of Interleukin-31 Gene Polymorphisms with Epithelial Ovarian Cancer in Chinese Population.
    Liu C; Wang Y; Song H; Li Q; Zhang Y; Chen P; Song Y; Su M; Huang Q; Wang M; Zhou B; Zhang L
    Dis Markers; 2018; 2018():3503858. PubMed ID: 29484036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population.
    Zhang Z; Zhou B; Wu Y; Gao Q; Zhang K; Song Y; Zhang L; Xi M
    Immunogenetics; 2014 Feb; 66(2):85-92. PubMed ID: 24352695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear G protein-coupled oestrogen receptor (GPR30) predicts poor survival in patients with ovarian cancer.
    Zhu CX; Xiong W; Wang ML; Yang J; Shi HJ; Chen HQ; Niu G
    J Int Med Res; 2018 Feb; 46(2):723-731. PubMed ID: 29239277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphism at miRNA-122-binding site in the IL-1α 3'UTR is associated with risk of epithelial ovarian cancer.
    Zhang Z; Zhou B; Gao Q; Wu Y; Zhang K; Pu Y; Song Y; Zhang L; Xi M
    Fam Cancer; 2014 Dec; 13(4):595-601. PubMed ID: 25195148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a common variant of SYNPO2 gene with increased risk of serous epithelial ovarian cancer.
    Ma L; Zhang W; Ding Z; Wu SG; Jin Y; Jiang N; Du H; Cai D; Miao L; Chen X
    Tumour Biol; 2017 Feb; 39(2):1010428317691185. PubMed ID: 28231729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Interleukin-31 gene polymorphisms with risk of cryptorchidism in a Chinese population.
    Zou B; Yu Z; Huang J; Tan C; Wang H; Fu J; Li X; Wang X; Cui S; Tang T
    Medicine (Baltimore); 2019 May; 98(22):e15861. PubMed ID: 31145337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer.
    Moxley KM; Benbrook DM; Queimado L; Zuna RE; Thompson D; McCumber M; Premkumar P; Thavathiru E; Hines L; Moore KN
    Gynecol Oncol; 2013 Aug; 130(2):377-82. PubMed ID: 23632208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the MUC16 gene: potential implication in epithelial ovarian cancer.
    Bouanene H; Hadj Kacem H; Ben Fatma L; Ben Limem H; Ben Ahmed S; Yakoub S; Miled A
    Pathol Oncol Res; 2011 Jun; 17(2):295-9. PubMed ID: 21046495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.
    Shi TY; Jiang Z; Jiang R; Yin S; Wang MY; Yu KD; Shao ZM; Sun MH; Zang R; Wei Q
    Tumour Biol; 2015 Sep; 36(9):6919-27. PubMed ID: 25854172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.
    Hedditch EL; Gao B; Russell AJ; Lu Y; Emmanuel C; Beesley J; Johnatty SE; Chen X; Harnett P; George J; ; Williams RT; Flemming C; Lambrechts D; Despierre E; Lambrechts S; Vergote I; Karlan B; Lester J; Orsulic S; Walsh C; Fasching P; Beckmann MW; Ekici AB; Hein A; Matsuo K; Hosono S; Nakanishi T; Yatabe Y; Pejovic T; Bean Y; Heitz F; Harter P; du Bois A; Schwaab I; Hogdall E; Kjaer SK; Jensen A; Hogdall C; Lundvall L; Engelholm SA; Brown B; Flanagan J; Metcalf MD; Siddiqui N; Sellers T; Fridley B; Cunningham J; Schildkraut J; Iversen E; Weber RP; Berchuck A; Goode E; Bowtell DD; Chenevix-Trench G; deFazio A; Norris MD; MacGregor S; Haber M; Henderson MJ
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24957074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.
    d'Adhemar CJ; Spillane CD; Gallagher MF; Bates M; Costello KM; Barry-O'Crowley J; Haley K; Kernan N; Murphy C; Smyth PC; O'Byrne K; Pennington S; Cooke AA; Ffrench B; Martin CM; O'Donnell D; Hennessy B; Stordal B; Finn S; McCann A; Gleeson N; D'Arcy T; Flood B; O'Neill LA; Sheils O; O'Toole S; O'Leary JJ
    PLoS One; 2014; 9(6):e100816. PubMed ID: 24977712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer.
    Li Q; Tang T; Zhang P; Liu C; Pu Y; Zhang Y; Song H; Wang Y; Song Y; Su M; Zhou B; Zhang L
    Fam Cancer; 2018 Oct; 17(4):577-585. PubMed ID: 29116431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2070-7. PubMed ID: 18708400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLIC1 a novel biomarker of intraperitoneal metastasis in serous epithelial ovarian cancer.
    Ye Y; Yin M; Huang B; Wang Y; Li X; Lou G
    Tumour Biol; 2015 Jun; 36(6):4175-9. PubMed ID: 25582317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
    Gayarre J; Kamieniak MM; Cazorla-Jiménez A; Muñoz-Repeto I; Borrego S; García-Donas J; Hernando S; Robles-Díaz L; García-Bueno JM; Ramón Y Cajal T; Hernández-Agudo E; Heredia Soto V; Márquez-Rodas I; Echarri MJ; Lacambra-Calvet C; Sáez R; Cusidó M; Redondo A; Paz-Ares L; Hardisson D; Mendiola M; Palacios J; Benítez J; García MJ
    J Gynecol Oncol; 2016 Jan; 27(1):e7. PubMed ID: 26463438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional polymorphisms in monocyte chemoattractant protein-1 are associated with increased susceptibility to ovarian cancer.
    Wei X; Tian Y; Lu W; Li W; Zhang M; Lu X; Liu Y
    DNA Cell Biol; 2015 Jan; 34(1):37-42. PubMed ID: 25289731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus.
    Huang HT; Chen JM; Guo J; Lan Y; Wei YS
    Rheumatol Int; 2016 Jun; 36(6):799-805. PubMed ID: 26769434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes.
    Li Y; Zhang HL; Kang S; Zhou RM; Wang N
    Gynecol Oncol; 2017 Jan; 144(1):140-145. PubMed ID: 27836206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.